...
首页> 外文期刊>Health economics >DRG prospective payment systems: refine or not refine?
【24h】

DRG prospective payment systems: refine or not refine?

机译:DRG预期付款系统:完善还是不完善?

获取原文
获取原文并翻译 | 示例

摘要

We present a model of contracting between a purchaser of health services and a provider (a hospital). We assume that hospitals provide two alternative treatments for a given diagnosis: a less intensive one (for example, a medical treatment) and a more intensive one (a surgical treatment). We assume that prices are set equal to the average cost reported by the providers, as observed in many OECD countries (yardstick competition). The purchaser has two options: (1) to set one tariff based on the diagnosis only and (2) to differentiate the tariff between the surgical and the medical treatment (i.e. to refine the tariff). We show that when tariffs are refined, the provider has always an incentive to overprovide the surgical treatment. If the tariff is not refined, the hospital underprovides the surgical treatment (and overprovides the medical treatment) if the degree of altruism is sufficiently low compared with the opportunity cost of public funds. Our main result is that price refinement might not be optimal.
机译:我们提出了卫生服务购买者与提供者(医院)之间的合同模型。我们假设医院针对给定的诊断提供两种替代治疗:一种强度较低的治疗(例如,医学治疗)和一种强度较高的治疗(外科治疗)。正如许多经合组织国家(标准竞争)所观察到的,我们假设价格设定为等于提供者报告的平均成本。购买者有两种选择:(1)仅根据诊断设置一个费率;(2)区分外科手术和药物治疗之间的费率(即优化费率)。我们证明,在提高关税后,医疗服务提供者总是有动机过度提供手术治疗。如果费率没有提高,如果利他主义的程度与公共资金的机会成本相比足够低,则医院将无法提供外科手术治疗(并会过度提供药物治疗)。我们的主要结果是价格优化可能不是最佳的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号